JPRN-UMIN000033511
Completed
未知
Effect of the combination therapy of liraglutide, a GLP-1 receptor analog, and IDegAsp in patients with type 2 diabetes - Effect of the combination therapy of liraglutide, a GLP-1 receptor analog, and IDegAsp
Yokohama City University Medical Center Department of Endocrinology and Diabetes0 sites60 target enrollmentJuly 26, 2018
ConditionsType2 diabetes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Type2 diabetes
- Sponsor
- Yokohama City University Medical Center Department of Endocrinology and Diabetes
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with severe renal dysfunction including patients requiring hemodialysis or peritoneal dialysis(eGFR\<30ml/min). 2\)pregnant 3\)Patients who have severe diabetic ketosis, diabetic coma. 4\)Patients with severe infection, severe injury or perioperative state.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetes.Diabetes Mellitus, Type 2MedDRA version: 19.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2011-002605-29-SEovo Nordisk A/S94
Active, not recruiting
Phase 1
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetes.Diabetes Mellitus, Type 2MedDRA version: 20.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitus System Organ Class: 100000072461Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2011-002605-29-GBovo Nordisk A/S135
Active, not recruiting
Phase 3
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetesHealth Condition 1: null- Diabetes Mellitus, Type 2Health Condition 2: E11- Type 2 diabetes mellitusCTRI/2013/10/004082ovo Nordisk AS
Active, not recruiting
Phase 1
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetes.Diabetes Mellitus, Type 2MedDRA version: 18.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2011-002605-29-ATovo Nordisk A/S150
Active, not recruiting
Phase 1
Efficacy and safety of liraglutide in combination with metformin compared to metformin alone, in children and adolescents with type 2 diabetes.Diabetes Mellitus, Type 2MedDRA version: 19.0Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2011-002605-29-NLovo Nordisk A/S150